- New ETFs
- Bond ETFs
- Currency ETFs
- Emerging Market ETFs
- Commodity ETFs
- Broad U.S. Equity ETFs
- Sector ETFs
- Specialty ETFs
Leerink Swann Lowers Price Target On Vivus To $9-$11
Recent Articles by Benzinga Staff
- TheStreet.com (TSCM) Gains Nasdaq Listing Compliance
- Drake Energy Surges On Gas Estimate
- Who Dat Commodity 2/8/10 (UNG, SLV)
- China BAK, Conn's Are Early Winners
- Three Banks With Rising Shares, Big Dividends (NYB, UBSI, DCOM)
Analyst Color
- Genesee & Wyoming, Inc. (GWR) Reports Solid Results For The Fourth-Quarter
- Corrections Corporation Of America’s (CXW) Fourth-Quarter Preview
- American Capital Agency Corp.’s (AGNC) Fourth-Quarter Review
- Taleo Corporation’s (TLEO) Fourth-Quarter Earnings Preview
- Patterson-UTI Energy, Inc. (PTEN) Maintains A Sector Perform Rating
Price Target
- FBR Gets Market Perform On SAP
- Morgan Stanley Ups Rockwell To Equal Weight
- Ritchie Bros. Auctioneers’ (RBA) Price Target Lowered
- Harman International Industries, Inc. (HAR) Price Target Raised
- SRX FQ2 Beats Marginally, Services Segment Robust, Losses At ERA
Analyst Ratings
- Genesee & Wyoming, Inc. (GWR) Reports Solid Results For The Fourth-Quarter
- Corrections Corporation Of America’s (CXW) Fourth-Quarter Preview
- American Capital Agency Corp.’s (AGNC) Fourth-Quarter Review
- Taleo Corporation’s (TLEO) Fourth-Quarter Earnings Preview
- Patterson-UTI Energy, Inc. (PTEN) Maintains A Sector Perform Rating
Posted on 11/04/09 at 6:37am by Benzinga Staff
Leerink Swann lowers its price target on Vivus (Nasdaq: VVUS) from $11-$13 to $9-$11.
Leerink lowered the price target due to potential safety issues with Vivus' late-stage diet drug Qnexa.
Bookmark/Search this post with:
Related Articles
Today's Trading Ideas
Featured Articles
There are 0 comments
Please note that comments may take up to one hour before they get published on the site. Please check back later to see your comments.
Post new comment
Receive Benzinga's Best 2010 Stock Idea!
